RCSI signed a major scientific agreement today with one of the largest and most respected American medical centres, Cleveland Clinic in Ohio. More ...

The agreement will enable the two institutions to collaborate on educational, research and innovation activities in the medical device industry and will contribute to the growth of the industry in Ireland and the United States.

The collaboration will enable growth of the research, development and design end of the medical device sector in Ireland. The agreement will enable RCSI and Cleveland Clinic to identify medical device market voids, encourage the development of medical device solutions, as well as partnering on clinical trials for CE and FDA approval.

Professor Oscar Traynor, Director of National Surgical Training Centre, RCSI, said: "The establishment of this scientific agreement helps to position Ireland at the forefront in Europe as an innovation hub and an innovator in clinical care. The agreement will enable the Centre for Innovation in Surgical Technology (CIST) and the Centre for Clinical Research and Development (CCR&D) to work in collaboration with Cleveland Clinic Innovations in the areas of orthopaedics, cardiovascular disease and general surgery and we look forward to working with Cleveland Clinic to further develop and enhance patient care.”

Chris Coburn, Executive Director, Innovations, Cleveland Clinic’s corporate venturing arm, said: "Cleveland Clinic was founded on a belief that an exceptional capacity for innovation should be valued. Collaborating with RCSI is a valuable extension of those core values, and we are thrilled to be working with such an esteemed institution."

Welcoming the agreement, Mr Frank Ryan, Chief Executive Officer, Enterprise Ireland, said: "The establishment of this scientific agreement between RCSI and Cleveland Clinic is a highly significant development. It provides a great opportunity for both organisations to work together to address complex healthcare challenges and develop innovative medical solutions that will ultimately improve patient outcomes and reduce healthcare costs.  It will deepen the innovation capability in the sector in Ireland, contributing to our global reputation in this field and helping to drive continued growth in the sector. Enterprise Ireland looks forward to continuing to support RCSI in its future international growth."